Science & Technology Current Affairs MCQs

Notes:
Recently, the World Health Organisation (WHO) certified Kenya as having eliminated human African trypanosomiasis (HAT), also known as sleeping sickness. It is a parasitic disease spread by infected tsetse fly bites, endemic in sub-Saharan Africa. It has two forms: Trypanosoma brucei gambiense (92% cases, chronic, found in West and Central Africa) and Trypanosoma brucei rhodesiense (8% cases, acute, found in East and Southern Africa). Rural communities relying on farming, fishing, herding, or hunting face higher risk. WHO has validated the gambiense form’s elimination in Togo, Benin, Ivory Coast, Uganda, Equatorial Guinea, Ghana, Chad, Guinea, and now Kenya.

Notes:
Recently, IIT Roorkee developed a new drug candidate, Compound 3b, to fight deadly drug-resistant bacteria. It targets KPC-2-producing Klebsiella pneumoniae, a World Health Organization (WHO) top-priority superbug. Compound 3b is a β-lactamase inhibitor that stops bacterial enzymes from breaking down antibiotics. It works with the antibiotic Meropenem, restoring its effectiveness against resistant infections. Preclinical lab and animal tests showed major infection reduction in lungs and safety to human cells. It marks a major step against antimicrobial resistance and boosts India’s role in global biomedical research.

Notes:
Union Minister of State for Science & Technology Jitendra Singh inaugurated India’s first ‘Animal Stem Cell Biobank’ at National Institute of Animal Biotechnology (NIAB), Hyderabad. NIAB is under Department of Biotechnology’s Biotechnology Research Innovation Council (BRIC). The Biobank will store high-quality stem cells from various animal species and supply cost-effective culture media to veterinary clinics, research bodies, and industry.

Notes:
Russia announced plans to launch the Venera-D mission to revisit Venus before 2036. Preliminary design work will begin in January 2026 under the new national space programme. The mission is being developed in collaboration with the Lavochkin Association. It will include a lander, a balloon probe, and an orbital spacecraft for comprehensive study of Venus. The design phase will take two years to complete. The launch is expected between 2034 and 2036, with the exact date decided after the design phase.

Notes:
On 21 August 2025, the Indian Council of Medical Research (ICMR) launched CEREBO, a portable non-invasive device to detect traumatic brain injuries (TBI). It uses near-infrared spectroscopy with machine learning to identify intracranial bleeding and edema within one minute, giving colour-coded, radiation-free results. The device is safe for infants and pregnant women and can be operated by paramedics or unskilled staff with just 30 minutes of training. It was developed by ICMR, AIIMS Bhopal, NIMHANS Bengaluru and Bioscan Research. India records over 1 lakh deaths and 10 lakh serious head injuries annually, making early TBI detection critical.

Notes:
The Department of Health and Human Services recently confirmed the first human case of the flesh-eating parasite, the New World screwworm, in the United States. New World screwworm is a blue-grey blowfly usually found in South America and the Caribbean. Its larvae burrow screwlike into living tissue, causing dangerous infestations. Female flies lay eggs in open wounds or cavities, with up to 3,000 eggs in their lifespan. Symptoms include non-healing wounds, bleeding, foul smell, and sensation of movement. Infestation is extremely painful and can be fatal if untreated.

Notes:
For decades, aspirin was the main drug to prevent heart attacks and strokes. A new study presented at the European Society of Cardiology congress and published in The Lancet shows clopidogrel, a blood-thinning antiplatelet drug, may be more effective. Review of seven clinical trials with 29,000 coronary artery disease patients found clopidogrel 14% more effective than aspirin in lowering major cardiovascular risks. Importantly, there was no higher risk of serious bleeding compared to aspirin. Clopidogrel (a P2Y₁₂ inhibitor) works by blocking platelet receptors to stop dangerous blood clots. It is low-cost, widely available, and safe, making it a strong candidate to replace aspirin in treatment guidelines.

Notes:
Indian Institute of Technology Hyderabad (IIT Hyderabad) signed a Memorandum of Understanding (MoU) with Army Training Command (ATC), Shimla. The partnership establishes a Centre of Excellence (CoE) named VIGRAHA (Virtual, Intelligent, Ground-breaking Research in AR/VR and High-tech Applications for Indian Army). The Simulator Development Division (SDD), Secunderabad represents the Indian Army in this collaboration. The CoE will focus on Augmented Reality (AR), Virtual Reality (VR), Artificial Intelligence (AI), Robotics, unmanned systems, and emerging defense technologies. The initiative strengthens India’s self-reliance (Atmanirbhar Bharat) in defense technologies.

Notes:
India’s largest Lithium-ion (Li-ion) battery manufacturing plant was inaugurated in Haryana on 5 September 2025. When fully operational, it will produce 20 crore battery packs annually, meeting nearly 40% of India’s 50 crore pack requirement. The plant was set up under the Centre’s Electronics Manufacturing Cluster (EMC) scheme. Li-ion batteries are rechargeable, with lithium ions moving between graphite (negative electrode) and lithium metal oxides (positive electrode) through a non-aqueous electrolyte. They offer high energy density (75-200 Wh/kg), are lightweight, use fewer toxic metals, and provide good cycle stability and efficiency. They have low self-discharge and no memory effect, ensuring reliable performance.

Notes:
India has licensed Indian Immunologicals Limited, Techinvention Lifecare Private Limited, Panacea Biotec Limited, Biological E Limited, and Zydus Lifesciences for manufacturing its first indigenous multi-stage malaria vaccine (AdFalciVax). The vaccine was developed by Indian Council of Medical Research (ICMR) and partners. It targets Plasmodium falciparum before it enters the bloodstream to prevent transmission. The vaccine is affordable, stable, scalable, and effective for over 9 months at room temperature.